Merck (NYSE: MRK) announced that it's Gardasil HPV (Human Papillomavirus) treatment is not effective in women over the age of 26 (specifically, ages 27-45). Although it had applied to the FDA to extend treatment for use by this age group, approval was denied.
Sales of Gardasil have been declining, as the market for this drug has been saturated. Gardasil is approved for young women (and also young men, aged 9-26). This is the second time that the FDA has disallowed wider use of the vaccine.
The full text of Merck's announcement can be found here:
http://bit.ly/gmcAeg
No comments:
Post a Comment